Article

Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Andersson, Ulf ORCID: 0000-0003-0316-3860, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2023) Glycyrrhizic acid inhibits high-mobility group box-1 and homocysteine-induced vascular dysfunction. Nutrients, 15 (14). ISSN 2072-6643

Swiderski, Jordan ORCID: 0000-0002-3613-2406, Sakkal, Samy ORCID: 0000-0003-0430-4012, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Zulli, Anthony ORCID: 0000-0002-2660-078X and Gadanec, Laura Kate ORCID: 0000-0002-4801-8061 (2023) Combination of taurine and black pepper extract as a treatment for cardiovascular and coronary artery diseases. Nutrients, 15 (11). ISSN 2072-6643

Swiderski, Jordan ORCID: 0000-0002-3613-2406, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Moore, Graham J, Kelaidonis, Konstantinos, Matsoukas, John ORCID: 0000-0001-5554-2964 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2023) Role of angiotensin II in cardiovascular diseases: introducing bisartans as a novel therapy for Coronavirus 2019. Biomolecules, 13 (5). ISSN 2218-273X

Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, McSweeney, Kristen, Kubatka, Peter, Caprnda, Martin, Gaspar, Ludovit, Prosecky, Robert, Dragasek, Jozef, Kruzliak, Peter, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2023) Angiotensin II constricts mouse iliac arteries: possible mechanism for aortic aneurysms. Molecular and cellular biochemistry. ISSN 0300-8177

McSweeney, Kristen, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Kubatka, Peter, Caprnda, Martin, Gaspar, Ludovit, Prosecky, Robert, Delev, Delian, Kruzliak, Peter, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2023) Cisplatin treatment reduces contraction to angiotensin II by altering expression of angiotensin II receptors: a pilot study. Molecular and Cellular Biochemistry. ISSN 0300-8177

Matsoukas, John ORCID: 0000-0001-5554-2964, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Kelaidonis, Konstantinos, Ligielli, Irene, Moschovou, Kalliopi, Georgiou, Nikitas, Plotas, Panagiotis, Chasapis, Christos T ORCID: 0000-0002-8728-6245, Moore, Graham, Ridgway, Harry and Mavromoustakos, Thomas ORCID: 0000-0001-5309-992X (2022) Diminazene aceturate reduces angiotensin II constriction and interacts with the spike protein of severe acute respiratory syndrome Coronavirus 2. Biomedicines, 10 (7). ISSN 2227-9059

Ridgway, Harry, Chasapis, Christos T ORCID: 0000-0002-8728-6245, Kelaidonis, Konstantinos, Ligielli, Irene, Moore, Graham J, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Mavromoustakos, Thomas ORCID: 0000-0001-5309-992X and Matsoukas, John ORCID: 0000-0001-5554-2964 (2022) Understanding the driving forces that trigger mutations in SARS‐CoV‐2: mutational energetics and the role of arginine blockers in COVID‐19 therapy. Viruses, 14 (5). ISSN 1999-4915

Ridgway, Harry, Moore, Graham J, Mavromoustakos, Thomas, Tsiodras, Sotirios, Ligielli, Irene, Kelaidonis, Konstantinos, Chasapis, Christos T, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Petty, Russell, Karakasiliotis, Ioannis, Gorgoulis, Vassilis G and Matsoukas, John ORCID: 0000-0001-5554-2964 (2022) Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2. Computational and Structural Biotechnology Journal, 20. pp. 2091-2111. ISSN 2001-0370

Moore, Graham J, Pires, Jose M, Kelaidonis, Konstantinos, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Matsoukas, John (2021) Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19. Biomolecules, 11 (7). ISSN 2218-273X

Liskova, Alena, Samec, Marek, Koklesova, Lenka, Brockmueller, Aranka, Zhai, Kevin, Abdellatif, Basma, Siddiqui, Manaal, Biringer, Kamil, Kudela, Erik, Pec, Martin, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Šudomová, Miroslava, Hassan, Sherif TS, Zulli, Anthony ORCID: 0000-0002-2660-078X, Shakibaei, Mehdi, Giordano, Frank A, Büsselberg, Dietrich, Golubnitschaja, Olga and Kubatka, Peter (2021) Flavonoids as an efective sensitizer for anti‑cancer therapy: insights into multi‑faceted mechanisms and applicability towards individualized patient profles. EPMA Journal, 12. pp. 155-176. ISSN 1878-5077

McSweeney, K ORCID: 0000-0003-4146-8251, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Qaradakhi, Tawar, Ali, Benazir, Zulli, Anthony ORCID: 0000-0002-2660-078X and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2021) Mechanisms of cisplatin‐induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers, 13 (7). ISSN 2072-6694

Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Qaradakhi, Tawar, McSweeney, K ORCID: 0000-0003-4146-8251, Ashiana Ali, B, Zulli, Anthony ORCID: 0000-0002-2660-078X and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2021) Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment. Future Microbiology, 16 (4). pp. 205-209. ISSN 1746-0913

Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, McSweeney, K ORCID: 0000-0003-4146-8251, Qaradakhi, Tawar, Ali, Benazir, Zulli, Anthony ORCID: 0000-0002-2660-078X and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2021) Can SARS-CoV-2 virus use multiple receptors to enter host cells? International Journal of Molecular Sciences, 22 (3). ISSN 1661-6596

McSweeney, Kristen, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Qaradakhi, Tawar, Gammune, Thushira Malindra, Kubatka, Peter, Caprnda, Martin, Fedotova, Julia, Radonak, Jozef, Kruzliak, Peter and Zulli, Anthony ORCID: 0000-0002-2660-078X (2020) Imipridone enhances vascular relaxation via FOXO1 pathway. Clinical and Experimental Pharmacology and Physiology, 47 (11). pp. 1816-1823. ISSN 0305-1870

Qaradakhi, Tawar, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Matsoukas, J, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2020) Could DIZE be the answer to COVID-19? Maturitas, 140. pp. 83-84. ISSN 0378-5122

Qaradakhi, Tawar, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, McSweeney, K, Abraham, JR, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2020) The anti-inflammatory effect of taurine on cardiovascular disease. Nutrients, 12 (9). pp. 1-23. ISSN 2072-6643

Qaradakhi, Tawar, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, McSweeney, Kristen, Tacey, Alexander, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Levinger, Itamar ORCID: 0000-0001-9194-2033, Rimarova, Kvetoslava, Egom, Emmanuel E, Rodrigo, L, Kruzliak, P, Kubatka, P and Zulli, Anthony ORCID: 0000-0002-2660-078X (2020) The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. Clinical and Experimental Pharmacology and Physiology. ISSN 0305-1870

Qaradakhi, Tawar, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Tacey, Alexander, Hare, DL, Buxton, Brian F, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Levinger, Itamar ORCID: 0000-0001-9194-2033 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2019) The Effect of Recombinant Undercarboxylated Osteocalcin on Endothelial Dysfunction. Calcified Tissue International. ISSN 0171-967X

Book Section

McSweeney, Kristen, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2022) Cardiovascular side effects of platinum-based chemotherapy. In: Platinum-Based Chemotherapy: Clinical Uses, Efficacy and Side Effects. Nurgali, K and Abalo Delgado, R, eds. Cancer Etiology, Diagnosis and Treatments . Nova Science Publishers, pp. 175-204.